Issue 1/2006
Content (35 Articles)
Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis
G. Dahlquist
Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus?
A. Kerssen, H. W. de Valk, G. H. A. Visser
Diabetes mellitus and impaired fasting glucose in Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
E. A. Carter, J. W. MacCluer, B. Dyke, B. V. Howard, R. B. Devereux, S. O. E. Ebbesson, H. E. Resnick
The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes
E. Kousta, Z. Efstathiadou, N. J. Lawrence, J. A. R. Jeffs, I. F. Godsland, S. C. Barrett, C. J. Doré, A. Penny, V. Anyaoku, B. A. Millauer, E. Cela, S. Robinson, M. I. McCarthy, D. G. Johnston
Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study
D. A. Lawlor, G. Davey Smith, S. Ebrahim
Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
R. N. Guzder, W. Gatling, M. A. Mullee, C. D. Byrne
Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women
A. Juutilainen, S. Lehto, T. Rönnemaa, K. Pyörälä, M. Laakso
Use of antimicrobials and risk of type 1 diabetes in a population-based mother–child cohort
A. Kilkkinen, S. M. Virtanen, T. Klaukka, M. G. Kenward, M. Salkinoja-Salonen, M. Gissler, M. Kaila, A. Reunanen
Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function
L. B. Nielsen, H. B. Mortensen, F. Chiarelli, R. Holl, P. Swift, C. de Beaufort, F. Pociot, P. Hougaard, S. Gammeltoft, M. Knip, L. Hansen
Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes
G. Andersen, J. Overgaard, A. Albrechtsen, C. Glümer, K. Borch-Johnsen, T. Jørgensen, T. Hansen, O. Pedersen
Increased vulnerability of newly forming beta cells to cytokine-induced cell death
J. J. Meier, R. A. Ritzel, K. Maedler, T. Gurlo, P. C. Butler
Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes
Z. Asghar, D. Yau, F. Chan, D. LeRoith, C. B. Chan, M. B. Wheeler
Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice
N. Shanmugam, I. T. Todorov, I. Nair, K. Omori, M. A. Reddy, R. Natarajan
Expression and function of leukaemia inhibitory factor and its receptor in normal and regenerating rat pancreas
S. De Breuck, L. Baeyens, L. Bouwens
Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy
U. Hiden, A. Maier, M. Bilban, N. Ghaffari-Tabrizi, C. Wadsack, I. Lang, G. Dohr, G. Desoye
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects
J. Westerbacka, A. Cornér, K. Kannisto, M. Kolak, J. Makkonen, E. Korsheninnikova, T. Nyman, A. Hamsten, R. M. Fisher, H. Yki-Järvinen
Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects
H. B. Holt, S. H. Wild, P. J. Wood, J. Zhang, A. A. Darekar, K. Dewbury, R. B. Poole, R. I. G. Holt, D. I. Phillips, C. D. Byrne
Pioglitazone increases non-esterified fatty acid clearance in upper body obesity
S. Shadid, M. D. Jensen
The in vivo effects of the Pro12Ala PPARγ2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank
G. D. Tan, M. J. Neville, E. Liverani, S. M. Humphreys, J. M. Currie, L. Dennis, B. A. Fielding, F. Karpe
Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin
J. L. Chan, V. Stoyneva, T. Kelesidis, P. Raciti, C. S. Mantzoros
The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes
S. Aiston, L. J. Hampson, C. Arden, P. B. Iynedjian, L. Agius
Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin
R. Palanivel, A. Maida, Y. Liu, G. Sweeney
The effect of intrauterine environment and low glomerular number on the histological changes in diabetic glomerulosclerosis
S. E. Jones, K. E. White, A. Flyvbjerg, S. M. Marshall
Visual acuity and perimetry as measures of visual function in diabetic macular oedema
E. Agardh, H. Stjernquist, A. Heijl, B. Bengtsson
Activator protein-1 in epiretinal membranes of patients with proliferative diabetic retinopathy
Y. Mitamura, A. Okumura, C. Harada, K. Namekata, K. Nakamura, A. Tashimo, K. Ohtsuka, T. Harada
PPARGC1A mRNA levels of in vitro differentiated human skeletal muscle cells are negatively associated with the plasma oleate concentrations of the donors
H. Staiger, N. Stefan, F. Machicao, A. Fritsche, H.-U. Häring
Comment on: Biason-Lauber A, Boehm B, Lang-Muritano M, et al (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905
D. -G. Geng, S. -Y. Liu, A. Steck, G. Eisenbarth, M. Rewers, J. -X. She
To: Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247–1257
M. Snijder, R. van Dam, M. Visser, D. Deeg, J. Seidell, P. Lips